Physician
Hematology
Dr. Richard A. Gams, MD
|
|
Give Review
Richard Gams is an expert in the field of Hematology. He went to medical school at State University of New York Downstate Medical Center College of Medicine. Dr. Richard A. Gams is a published MD as well. He has 76 publications published. The latest was: The final dilemma. End-of-life treatment decisions.
Publications
- Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma.
- Interferon alpha-2a and dacarbazine in melanoma.
- Phase I-II trial of high-dose epirubicin in patients with lymphoma.
- Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone.
- Phase I-II study of epirubicin in multiple myeloma.
- Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
- Phase I-II trial of mitoxantrone in acute leukemia: an interim report.
- Phase I-II trial of mitoxantrone in acute leukemia.
- Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
- Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinoma.
- Phase III trials of toremifene vs tamoxifen.
- Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
- Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
- Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck. A Southeastern Cancer Study Group trial.
- Phase II study of mitoxantrone in patients with metastatic breast carcinoma: a Southeastern Cancer Study Group project.
- The psychosocial support status of elderly cancer outpatients.
- Results of a uniform histopathologic review system of lymphoma cases. A ten-year study from the Southeastern Cancer Study Group.
- Mitoxantrone in malignant melanoma.
- Treatment of metastatic sarcomas with mitoxantrone.
- The final dilemma. End-of-life treatment decisions.
- Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
- Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
- Mitoxantrone in malignant lymphomas.
- Malignant lymphoma, mixed cell type, diffuse.
- Red cell enzymes in acute leukemia in relapse & remission.
- Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
- Mitoxantrone in malignant lymphoma.
- Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial.
- Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
- A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma.
- Phase II study of intravenous idarubicin in unfavorable non-Hodgkin''s lymphoma.
- Antiestrogenic potency of toremifene and tamoxifen in postmenopausal women.
- Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study.
- Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer.
- Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with an intensive epirubicin-containing regimen.
- Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate.
- Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer.
- Complications of chemotherapy in the treatment of Hodgkin's disease.
- The Alabama Breast Cancer Project.
- Dystonia with droperidol therapy.
- Do information systems improve the quality of clinical research? Results of a randomized trial in a cooperative multi-institutional cancer group.
- Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group.
- Subcategories of histiocytic lymphoma: associations with survival and reproducibility of classification. The Southeastern Cancer Study Group experience.
- Lymphoblastic lymphoma: a clinicopathologic study of 95 patients.
- Some comments on interferon.
- How we manage recurrent breast cancer.
- Pseudolymphoma induced by diphenylhydantoin.
- Hydantoin-induced pseudo-pseudolymphoma.
- In vitro binding of 67Ga to L1210 cells.
- Delivery of 57Co B12 to lymphoblasts derived from mice with transplanted 1210 ascites tumor cells by transcobalamins I, II, and III.
- Studies on vitamin B 12 binders of human serum. (I) Isolation and characterization.
- Effects of buffers and pH on in vitro binding of 67Ga by L1210 leukemic cells.
- Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
- Uptake and subcellular distribution of vitamin B12 in mouse L1210 leukemic lymphoblasts.
- A phase I trial of ametantrone acetate (NSC-287513).
- Weekly mitoxantrone therapy for refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
- Weekly mitoxantrone therapy of Hodgkin's disease, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. A Southeastern Cancer Study Group Trial.
- Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease. A Southeastern Cancer Study Group trial.
- Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.
- Protein-mediated uptake of vitamin B12 by isolated mitochondria.
- Metabolism of cyanocobalamin by L-1210 leukemic lymphoblasts.
- Serum inhibition of in vitro 67Ga binding by L1210 leukemic cells.
- Comparison of biochemical properties of human serum B12 binders derived from sephadex and DEAE-cellulose chromatography.
- Effect of growth rate and simian adenovirus-7 transformation on in vitro 67Ga binding to hamster embryo cells.
- Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin''s disease.
- BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin''s disease.
- Inhibition of lysozyme by polyvalent metal ions.
- Preliminary x-ray study of crystals of human transferrin.
- A common progenitor for human myeloid and lymphoid cells.
- Cellular fluxes of vitamin B12.
- Effect of hypoxia on 67Ga incorporation into human granulocytes.
- Ferrocyanide staining of transferrin and ferritin-conjugated antibody to transferrin.
- BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin''s lymphoma.
- Demonstration of Cryptococcus neoformans in a stained bone marrow specimen.
- Hematologic toxicity from bleomycin in advanced cancer patients.
Schools
Suny Downstate Medical Center
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
San Antonio Uniformed Services Health Education Consortium -
SUNY Health Science Center at Brooklyn -
State University of New York Downstate Medical Center College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Vivek V. Abhyankar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Moniba Nazeef, MD |